trial

Multifamily Psychoeducation and Cognitive Remediation for Recent-Onset Psychosis

NCTId NCT01196286
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 40 (estimated)
Sponsored by University of Arizona
Primary completion 2017-04
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
40 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2010-06
Primary completion
2017-04
Eligibility
ALL · 18 Years · 35 Years

Interventions & indications

Drugs
Multifamily Group Psychoeducation (MFG)Cognitive Remediation (CR)

Sponsors

University of ArizonaLead Sponsor
Institute for Mental Health ResearchCollaborator

Investigators

1
Nicholas Breitborde, Ph.D.Principal Investigator

Sites

1 total
Tucson, United States

Facts & assertions

4 sourced
Enrollment
40
Phase
NA
Primary Completion Date
2017-04
Status
COMPLETED
relationships
The graph out of here
drug
Multifamily Group Psychoeducation (MFG)
drug
Cognitive Remediation (CR)
drug
lead_sponsor
University of Arizona
company
collaborator
Institute for Mental Health Research
company
indication
Psychotic Disorder Not Otherwise Specified (NOS)
indication
Schizoaffective Disorder
indication
Recent-Onset Psychosis
indication
investigator
Nicholas Breitborde, Ph.D.
person